Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
forgiftning med valproatnatrium |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
accidentel forgiftning med valproatnatrium |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
|
tilsigtet forgiftning med valproatnatrium |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
|
forgiftning med valproatnatrium, uvist med hvilken hensigt |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate adverse reaction |
Causative agent |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
overdosis af natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
accidentel overdosis af natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
tilsigtet overdosis af natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
overdosis af natriumvalproat, uvist med hvilken hensigt |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
natriumvalproat 400 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat til parenteral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat 500 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat 250 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
[X]Valproic acid causing adverse effects in therapeutic use |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
|
accidentel forgiftning med valproatnatrium |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
tilsigtet forgiftning med valproatnatrium |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
natriumvalproat tablet med modificeret udløsning til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat 100 mg tablet der kan knuses |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat 200 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat 300 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat 500 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat 200 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
natriumvalproat 200 mg/5 ml sukkerfri oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
Sodium valproate 200 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
Sodium valproate 500 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
Sodium valproate blood measurement |
Component |
False |
Sodium valproate |
Inferred relationship |
Some |
2 |
Serum sodium valproate measurement |
Component |
False |
Sodium valproate |
Inferred relationship |
Some |
2 |
Valproate sodium 100mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
allergi over for natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 100mg conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Some |
|
Sodium valproate 300 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 300 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 200 mg gastro-resistant oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 200 mg gastro-resistant oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 500 mg gastro-resistant oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 500 mg gastro-resistant oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 500 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 500 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 200 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 200 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 400 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 400 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 40 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 40 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
allergi over for natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 100 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 100 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Product containing precisely sodium valproate 166.76 milligram and valproic acid 72.61 milligram/1 sachet prolonged-release oral granules (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Product containing precisely sodium valproate 166.76 milligram and valproic acid 72.61 milligram/1 sachet prolonged-release oral granules (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
Product containing precisely sodium valproate 1 gram/1 sachet prolonged-release oral granules (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 1 gram/1 sachet prolonged-release oral granules (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 150 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 150 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 300 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 300 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 600 mg gastro-resistant oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 600 mg gastro-resistant oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 150 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 150 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 300 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 300 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 60 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 60 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 500 mg prolonged-release oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 500 mg prolonged-release oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 100 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 100 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 100 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate 100 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Serum sodium valproate measurement |
Component |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
Sodium valproate blood measurement |
Component |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |